JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Akduman, D.
Right arrow Articles by Judson, F. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Akduman, D.
Right arrow Articles by Judson, F. N.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, January 2002, p. 281-283, Vol. 40, No. 1
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.1.281-283.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Evaluation of a Strand Displacement Amplification Assay (BD ProbeTec-SDA) for Detection of Neisseria gonorrhoeae in Urine Specimens

Deniz Akduman,1 Josephine M. Ehret,1,2 Kimberly Messina,1 Sharron Ragsdale,1 and Franklyn N. Judson1,2,3*

Denver Public Health Department,1 Departments of Medicine,2 Preventive Medicine, University of Colorado Health Sciences Center, Denver, Colorado3

Received 13 June 2001/ Returned for modification 25 July 2001/ Accepted 15 October 2001

The performance of a strand displacement amplification assay (the BDProbeTec-SDA assay) in detecting Neisseria gonorrhoeae in urine specimens was evaluated. When performed under stringent quality control conditions, the BDProbeTec-SDA assay is a sensitive, specific, and efficient method for the screening of large numbers of noninvasively obtained specimens. Because the predictive value of an assay is a function of the prevalence of the disease, culture confirmation is needed for samples with positive results from populations in which the prevalence of a disease is low or in situations in which false-positive results may have important medical, psychosocial, or medicolegal consequences.

* Corresponding author. Mailing address: Denver Public Health, 605 Bannock St., Denver, CO 80204-4507. Phone: (303) 436-7200. Fax: (303) 436-7211. E-mail: Frank.Judson{at}dhha.org.

Journal of Clinical Microbiology, January 2002, p. 281-283, Vol. 40, No. 1
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.1.281-283.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2002 by the American Society for Microbiology. All rights reserved.